Loading...
Mochida Pharmaceutical Co., Ltd.
4534.T•JPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥3230.00
¥135.00(4.36%)
Mochida Pharmaceutical Co., Ltd. (4534.T) Financial Performance & Income Statement Overview
Review Mochida Pharmaceutical Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.21%
↑ 2.21%
Operating Income Growth
40.07%
↑ 40.07%
Net Income Growth
25.03%
↑ 25.03%
Operating Cash Flow Growth
225.05%
↑ 225.05%
Operating Margin
7.73%
↑ 7.73%
Gross Margin
51.15%
↑ 51.15%
Net Profit Margin
5.41%
↑ 5.41%
ROE
4.39%
↑ 4.39%
ROIC
6.010%
↑ 6.010%
Mochida Pharmaceutical Co., Ltd. (4534.T) Income Statement & Financial Overview
Review Mochida Pharmaceutical Co., Ltd.'s (4534.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $24.43B | $29.64B | $25.69B | $25.41B |
| Cost of Revenue | $12.09B | $13.47B | $13.36B | $12.45B |
| Gross Profit | $12.34B | $16.16B | $12.33B | $12.96B |
| Gross Profit Ratio | $0.51 | $0.55 | $0.48 | $0.51 |
| R&D Expenses | $0.00 | $4.78B | $2.45B | $2.33B |
| SG&A Expenses | $11.46B | $12.71B | $8.28B | $8.44B |
| Operating Expenses | $11.46B | $12.71B | $10.73B | $10.80B |
| Total Costs & Expenses | $23.55B | $26.18B | $24.09B | $23.22B |
| Interest Income | $20.00M | $5.00M | $4.00M | $0.00 |
| Interest Expense | $1.00M | -$186.00M | $0.00 | $0.00 |
| Depreciation & Amortization | $773.00M | $749.00M | $713.00M | $705.00M |
| EBITDA | $1.10B | $4.20B | $2.42B | $3.07B |
| EBITDA Ratio | $0.04 | $0.14 | $0.09 | $0.12 |
| Operating Income | $883.00M | $3.45B | $1.60B | $2.19B |
| Operating Income Ratio | $0.04 | $0.12 | $0.06 | $0.09 |
| Other Income/Expenses (Net) | -$460.00M | $111.00M | $101.00M | $174.00M |
| Income Before Tax | $423.00M | $3.56B | $1.70B | $2.36B |
| Income Before Tax Ratio | $0.02 | $0.12 | $0.07 | $0.09 |
| Income Tax Expense | $344.00M | $781.00M | $433.00M | $809.00M |
| Net Income | $80.00M | $2.78B | $1.27B | $1.55B |
| Net Income Ratio | $0.003 | $0.09 | $0.05 | $0.06 |
| EPS | $2.26 | $78.42 | $35.85 | $43.83 |
| Diluted EPS | $2.26 | $78.42 | $35.85 | $43.83 |
| Weighted Avg Shares Outstanding | $35.45M | $35.45M | $35.45M | $35.45M |
| Weighted Avg Shares Outstanding (Diluted) | $35.45M | $35.45M | $35.45M | $35.45M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan